Skip to main content

Table 3 Certainty of the evidence for outcomes of the main analysis

From: Is metabolic syndrome a risk factor in hepatectomy? A meta-analysis with subgroup analysis for histologically confirmed hepatic manifestations

Outcome

№ of included studies

Certainty of the evidence (GRADE)

Relative effect

(95% CI)

Overall complications

11 (retrospective)

LOW

OR 1.55

[1.05; 2.29]

Major complications

8 (retrospective)

LOW

OR 1.97

[1.13; 3.43]

Minor complications

8 (retrospective)

VERY LOW

OR 0.72

[0.41; 1.29]

PHLF

6 (retrospective)

VERY LOW

OR 1.83

[0.86; 3.91]

Postoperative biliary leakage

8 (retrospective)

LOW

OR 1.43

[0.77; 2.63]

Postoperative hemorrhage

5 (retrospective)

LOW

OR 1.76

[1.23; 2.50]

Postoperative infection

8 (retrospective)

LOW

OR 1.63

[1.03; 2.57]

Perioperative mortality

2 (retrospective)

VERY LOW

OR 4.84

[0.00; 41157788.03]

90-days mortality

5 (retrospective)

LOW

OR 1.55

[0.76; 3.15]

1-year overall survival

5 (retrospective)

LOW

OR 0.83

[0.32; 2.14]

5-years overall survival

6 (retrospective)

LOW

OR 1.07

[0.79; 1.45]

Recurrence

4 (retrospective)

LOW

OR 1.06

[0.87; 1.30]

1-year recurrence-free survival

4 (retrospective)

LOW

OR 0.95

[0.47; 1.92]

5-year recurrence-free survival

5 (retrospective)

LOW

OR 1.20

[0.91; 1.59]

  1. CI confidence interval, OR odds ratio